Open AccessLisocabtagene Maraleucel (Breyanzi)
Author(s) -
CADTH
Publication year - 2022
Publication title -
canadian journal of health technologies
Language(s) - Uncategorized
Resource type - Journals
ISSN - 2563-6596
DOI - 10.51731/cjht.2022.396
Subject(s) - chimeric antigen receptor , medicine , lymphoma , b cell lymphoma , cancer , immunotherapy